Gut Podcast
By BMJ Group
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by BMJ Group
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 33
Reviews: 0
Episodes: 117
Description
The Gut Podcast is your go-to source for the latest discussions in gastroenterology and hepatology. Each month Dr. Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, dives into key issues in the field by discussing articles with their authors.
Gut - gut.bmj.com - is an international journal from BMJ Group and the British Society of Gastroenterology (BSG) publishing research and review articles in gastroenterology and hepatology.
Stay up to date with the latest research in gastroenterology. Subscribe to the Gut podcast.
| Episode | Date |
|---|---|
|
Predicting sensitivity to dietary emulsifiers using an in-vitro microbiota model
|
May 01, 2025 |
|
Antiviral treatment of chronic Hepatitis B
|
Apr 01, 2025 |
|
Single-cell spatial profiling of immunotypes in hepatocellular carcinoma
|
Mar 03, 2025 |
|
Understanding the gut-adipose-liver axis and its impact on insulin action
|
Feb 04, 2025 |
|
Linking breastfeeding and atopic dermatitis in infants
|
Jan 06, 2025 |
|
Improving CLDN18.2 BiTEs efficacy against pancreatic cancer
|
Dec 02, 2024 |
|
Gut microbiota signatures of vulnerability to food addiction in mice and humans
|
Nov 01, 2024 |
|
Gastric intestinal metaplasia: reviewing current guidelines
|
Oct 01, 2024 |
|
Exploring stem cell therapy for Hirschsprung disease
|
Sep 02, 2024 |
|
Protective function of sclerosing cholangitis on IBD
|
Aug 01, 2024 |
|
Linking high-fat diet and liver tumorigenesis
|
Jul 01, 2024 |
|
Hepatocellular carcinoma in patients with liver cirrhosis
|
Jun 03, 2024 |
|
Microbiome interventions for COPD protection
|
May 01, 2024 |
|
MASLD: a systemic metabolic disorder with cardiovascular and malignant complications
|
Apr 02, 2024 |
|
RE.GA.IN: the Real-world Gastritis Initiative
|
Mar 01, 2024 |
|
Prebiotic diet changes neural correlates of food decision-making in overweight adults
|
Feb 02, 2024 |
|
Lethal sepsis prevention with novel tripeptide RKH derived from Akkermansia muciniphila
|
Jan 05, 2024 |
|
Special Gut Podcast: Digestive health and climate change
|
Dec 06, 2023 |
|
Gastrointestinal origins for Parkinson’s disease
|
Nov 01, 2023 |
|
Consensus definition of sludge and microlithiasis as a possible cause of pancreatitis
|
Oct 02, 2023 |
|
Rome consensus on gut microbiota and faecal microbiota transplantation in IBD
|
Sep 01, 2023 |
|
The therapeutic potential of fasting
|
Aug 01, 2023 |
|
Helicobacter pylori promotes colorectal carcinogenesis
|
Jul 03, 2023 |
|
Single-cell transcriptomics sheds new light on pancreas biology and disease
|
Jun 01, 2023 |
|
Counteracting the harm of dietary emulsifiers with Akkermansia muciniphila
|
Apr 27, 2023 |
|
Antibiotic use as a risk factor for IBD
|
Mar 22, 2023 |
|
Predicting disease progression in bridging fibrosis and cirrhosis with liver stiffness
|
Feb 27, 2023 |
|
Assessing the impact of dietary fibre on bile acid transformation by gut bacteria in mice
|
Jan 27, 2023 |
|
Autoimmune gastritis: cancer risk in consistently tested H. pylori-negative patients
|
Jan 04, 2023 |
|
FMT-AID trial shows effectiveness in inducing remission of ulcerative colitis
|
Nov 28, 2022 |
|
Endoscopic pyloromyotomy for the treatment of severe and refractory gastroparesis
|
Nov 01, 2022 |
|
Climate change: a survey of global gastroenterology society leadership
|
Oct 10, 2022 |
|
Management of Helicobacter pylori infection — the Maastricht VI/Florence Consensus Report
|
Sep 08, 2022 |
|
Kyoto international consensus report on the gastro-oesophageal junction
|
Aug 18, 2022 |
|
A faecal microbiota signature with high specificity for pancreatic cancer
|
Jul 18, 2022 |
|
PICaSSO Histologic Remission Index in ulcerative colitis: a novel simplified histological score
|
Jun 20, 2022 |
|
Next-generation sequencing of bile cell-free DNA for early detection of malignant biliary strictures
|
Jun 06, 2022 |
|
Endoscopic full-thickness plication for the treatment of PPI-dependent GERD
|
Mar 30, 2022 |
|
Dysosmobacter welbionis, a new human commensal bacterium preventing diet-induced obesity
|
Feb 28, 2022 |
|
Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory Pg-LPS
|
Jan 28, 2022 |
|
Proton pump inhibitors and risk of colorectal cancer
|
Jan 06, 2022 |
|
Sugar-sweetened beverage intake and risk of early-onset colorectal cancer among women
|
Nov 25, 2021 |
|
Diet quality and risk and severity of COVID-19: a prospective cohort study
|
Oct 29, 2021 |
|
Helicobacter pylori resistance to antibiotics in Europe
|
Oct 01, 2021 |
|
Blue poo: impact of gut transit time on the gut microbiome using a novel marker
|
Sep 08, 2021 |
|
Long-term dietary patterns associated with inflammatory features of the gut microbiome
|
Jul 01, 2021 |
|
Association between Brachyspira and irritable bowel syndrome with diarrhoea
|
Jun 01, 2021 |
|
Effect of IBD medications on COVID-19 outcomes
|
May 12, 2021 |
|
CLARITY IBD: Anti-SARS-CoV-2 antibody and vaccination responses in patients treated with infliximab
|
Apr 23, 2021 |
|
Long-term instability of the intestinal microbiome and its associations
|
Apr 06, 2021 |
|
Neutrophils interact with cholangiocytes to cause cholestatic changes in alcoholic hepatitis
|
Mar 10, 2021 |
|
Screening and eradication of Helicobacter pylori for gastric cancer prevention
|
Feb 01, 2021 |
|
European Registry on Helicobacter pylori management (Hp-EuReg)
|
Jan 09, 2021 |
|
Driving the efficacy of prebiotic intervention in obese patients
|
Nov 15, 2020 |
|
Adipose tissue derived bacteria are associated with inflammation in obesity and type 2 diabetes
|
Oct 19, 2020 |
|
Global burden of oesophageal and gastric cancer by histology and subsite in 2018
|
Sep 26, 2020 |
|
Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease
|
Aug 13, 2020 |
|
Efficacy of FMT for patients with IBS in a randomised, double-blind, placebo-controlled study
|
Jul 19, 2020 |
|
Infants born to mothers with IBD present with altered gut microbiome
|
Jun 22, 2020 |
|
Mediterranean diet intervention alters the gut microbiome in older people
|
May 31, 2020 |
|
Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus
|
May 03, 2020 |
|
British Society of Gastroenterology guidance for management of IBD during the Covid-19 pandemic
|
Apr 22, 2020 |
|
Global patterns and trends in colorectal cancer incidence in young adults
|
Mar 29, 2020 |
|
Guidelines on the management of inflammatory bowel disease in adults
|
Nov 21, 2019 |
|
European evidence-based guidelines on pancreatic cystic neoplasms
|
Aug 20, 2018 |
|
Viral transfer during FMT linked to better outcomes in recurrent C. diff bacterial infections
|
May 11, 2018 |
|
Colorectal cancer: research prioritisation needed in third most lethal malignancy worldwide
|
Mar 15, 2018 |
|
Development of an FGF19-based chimeric molecule to promote fatty liver regeneration
|
Nov 26, 2017 |
|
Feeding the microbiota: transducer of nutrient signals for the host
|
Oct 29, 2017 |
|
Dietary emulsifiers directly alter human microbiota composition
|
Aug 16, 2017 |
|
Faecal microbiota transplantation in clinical practice
|
Jun 20, 2017 |
|
BMP-9 interferes with liver regeneration and promotes liver fibrosis
|
May 31, 2017 |
|
A systematic review of isolated colonic Crohn’s disease: the third IBD?
|
Feb 27, 2017 |
|
Gut microbiome and liver diseases
|
Feb 02, 2017 |
|
Antibiotics as deep modulators of gut microbiota: between good and evil.
|
Jan 04, 2017 |
|
Asia-Pacific consensus on the management of gastro-oesophageal reflux disease
|
Oct 19, 2016 |
|
Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma
|
Sep 22, 2016 |
|
Live birth and adverse birth outcomes in women with ulcerative colitis and Crohn’s disease
|
Jun 17, 2016 |
|
GLP-1 based therapies: clinical implications for gastroenterologists
|
May 24, 2016 |
|
Dysbiotic gut microbiota causes transmissible Crohn’s disease-like ileitis
|
Mar 23, 2016 |
|
Mesalazine and thymoquinone attenuate intestinal tumour development in mice
|
Mar 08, 2016 |
|
Effects of bowel cleansing on the intestinal microbiota
|
Jan 25, 2016 |
|
Development of an enhanced human gastrointestinal epithelial culture system
|
Aug 28, 2015 |
|
Helicobacter pylori targets cancer-associated apical-junctional constituents
|
Jun 16, 2015 |
|
Diagnosis and management of acute kidney injury in patients with cirrhosis
|
May 29, 2015 |
|
Demonstration of the usefulness of epigenetic cancer risk prediction
|
Apr 27, 2015 |
|
XIAP variants in male Crohn’s disease
|
Feb 10, 2015 |
|
Cell lineage distribution atlas reveals heterogeneous gland populations in the gastric antrum
|
Jan 02, 2015 |
|
Classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn’s disease
|
Oct 24, 2014 |
|
Update on basic and clinical aspects of eosinophilic oesophagitis
|
Sep 25, 2014 |
|
AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition
|
Aug 21, 2014 |
|
Besifovir versus entecavir in Asian patients with chronic hepatitis B
|
Aug 15, 2014 |
|
Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea
|
Jun 09, 2014 |
|
Recent advances in clinical practice challenges and opportunities in the management of obesity
|
Apr 29, 2014 |
|
Amniotic stem cell treament for necrotic enterocolitis
|
Feb 21, 2014 |
|
British Society of Gastroenterology guidelines on diagnosing and managing Barrett’s oesophagus
|
Jan 31, 2014 |
|
Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients
|
Nov 29, 2013 |
|
A systematic approach to therapeutic target selection in oesophago-gastric cancer
|
Nov 15, 2013 |
|
Gut podcast: Treatment of pancreatic fibrosis with siRNA
|
Oct 22, 2013 |
|
Intra-tumoural stroma as a predictor of survival in patients with gastric cancer
|
Aug 02, 2013 |
|
Probiotics in health and disease
|
Jul 25, 2013 |
|
Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission
|
Jul 25, 2013 |
|
mTNF reverse signalling induced by TNFα antagonists involves a GDF-1 dependent pathway
|
Apr 24, 2013 |
|
Endoscopic improvement of mucosal lesions in patients with ileocolonic Crohn’s disease
|
Apr 24, 2013 |
|
Bowel cancer screening in England
|
Feb 21, 2013 |
|
PUFAS and neoplasms
|
Feb 21, 2013 |
|
Cancer treatment induced gastrointestinal symptoms
|
Feb 21, 2013 |
|
Bifidobacterium and gastrointestinal inflammation
|
Feb 21, 2013 |
|
High-fat diet and gut microbiota
|
Feb 21, 2013 |
|
Management of Helicobacter pylori infection
|
Feb 21, 2013 |
|
Assessment of colorectal cancer molecular features
|
Feb 21, 2013 |
|
Probiotic and postbiotic activity in health and disease
|
Feb 21, 2013 |
|
NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease
|
Feb 21, 2013 |
|
Outcomes of the Bowel Cancer Screening Programme in England
|
Feb 21, 2013 |
|
Mucosal healing in inflammatory bowel disease
|
Feb 21, 2013 |
|
Interleukin 13 and its role in gut defence and inflammation
|
Feb 21, 2013 |
|
Revising the classification of acute pancreatitis
|
Feb 21, 2013 |